EP1326643 - Bibliographic data

INHIBITION OF EMETIC EFFECT OF METFORMIN WITH 5-HT3 RECEPTOR ANTAGONISTS

Last update 12/06/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

DEPOMED, INC.

1360 O`Brien Drive
Menlo Park, CA 94025
États-Unis d'Amérique
(72) Inventors

COWLES, Verne, E.

10857 McPeak Lane
Dublin, CA 94568
États-Unis d'Amérique
(74) Agent

Mail recipient

MURPHY, COLM DAMIEN ET AL

Boult Wade Tennant Verulam Gardens 70 Gray`s Inn Road
London WC1X 8BT
Royaume-Uni

(21) Request number EP01980020.0
(22) Request date 16/10/2001

(11) Publication number EP1326643
Publication date 28/12/2005

(54) Title of the invention INHIBITION OF EMETIC EFFECT OF METFORMIN WITH 5-HT3 RECEPTOR ANTAGONISTS
(51) International classification None
International classification (before reform)

Claimed priority

(31) Number: 691398
(32) Date: 17/10/2000
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 6 - Amount: 70 € - Due date 31/10/2006
Surtax: 6 - Amount: 14 € - Due date 01/05/2007
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/4, of 31/12/2005

History

Publication de la délivrance du brevet européen - Legal date 28/12/2005


Déchéance du brevet d'invention après période de grâce - Legal date 31/10/2006


Entrée en période de grâce du brevet d'invention - Legal date 31/10/2006